Fresenius Medical Care AG (NYSE:FMS – Get Free Report) saw a large drop in short interest in August. As of August 15th, there was short interest totalling 632,800 shares, a drop of 26.0% from the July 31st total of 855,500 shares. Based on an average trading volume of 333,000 shares, the short-interest ratio is presently 1.9 days.
Fresenius Medical Care Trading Down 0.3 %
Fresenius Medical Care stock opened at $19.37 on Friday. Fresenius Medical Care has a 1 year low of $16.37 and a 1 year high of $24.48. The firm’s 50-day moving average is $19.30 and its 200-day moving average is $19.91. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.14 and a current ratio of 1.46. The company has a market cap of $11.37 billion, a P/E ratio of 21.75, a PEG ratio of 1.01 and a beta of 0.90.
Fresenius Medical Care (NYSE:FMS – Get Free Report) last issued its earnings results on Tuesday, July 30th. The company reported $0.38 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.38. The firm had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.28 billion. Fresenius Medical Care had a net margin of 2.72% and a return on equity of 5.48%. On average, equities analysts expect that Fresenius Medical Care will post 1.5 earnings per share for the current year.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on FMS. Truist Financial cut their target price on shares of Fresenius Medical Care from $24.00 to $22.00 and set a “hold” rating on the stock in a research note on Wednesday, July 31st. StockNews.com initiated coverage on Fresenius Medical Care in a research note on Thursday. They set a “strong-buy” rating on the stock. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, one has given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $22.00.
Get Our Latest Analysis on FMS
About Fresenius Medical Care
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Featured Articles
- Five stocks we like better than Fresenius Medical Care
- What is a SEC Filing?
- Does A&F’s Q2 Earnings Win Point to a Strong Holiday Season?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Best Buy Stock Flashes Bullish Signal, Challenges Remain
- What is a buyback in stocks? A comprehensive guide for investors
- Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.